Lupin's Goa facility inspected by U.S. FDA; form-483 issued with seven observations



Lupin said the U.S. Food and Drug Administration (FDA) conducted an inspection at its Goa manufacturing facility from 10 November to 21 November 2025.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *